Alcaftadine is an anti-allergy eye drop. It is a sustained-released form of an antihistamine that helps to reduce itching, redness, and other allergic symptoms of the eyes. The active ingredient in alcaftadine is an H1 receptor antagonist, which works by blocking a particular kind of cell receptor responsible for inflammation. Alcaftadine is used to treat seasonal allergic conjunctivitis, a common eye condition.
Alcaftadine is used in the treatment of ocular itching, redness, and tearing due to allergies. It is also used for the symptomatic treatment of ocular itching due to allergic conjunctivitis. Alcaftadine is also used to reduce seasonal allergic symptoms, such as swollen eyes, itchy and runny nose, sneezing, and watery eyes.
| Brand Name | Alcaftadine |
|---|---|
| Type | |
| Weight | |
| Generic | Alcaftadine |
| Manufacturer | |
| Available in | English বাংলা |
The active ingredient in Alcaftadine , an H1 receptor antagonist, works by blocking the H1 histamine receptor and preventing the release of inflammatory mediators that causes allergenic symptoms such as itching, redness and tearing. By blocking the H1 histamine receptor, Alcaftadine can reduce the number of histamine receptors available and thus, reduce the severity of allergic symptoms.
The effects of Alcaftadine usually begin to be felt within a few minutes after using an eye drop, with maximum effects occuring anywhere from 15 minutes to 2 hours after administration. However, some patients may take a few days of consistent use before the effects start to become noticeable.
Alcaftadine is quickly and efficiently absorbed when administered in the form of eye drops. The time saved in absorption and result in a faster onset of action for symptom relief.
Alcaftadine is eliminated primarily through the bile and urine, as well as other metabolic pathways such as enzyme-mediated processes.
The appropriate dose of Alcaftadine will vary depending on the patient's age, weight, and medical condition. Generally, adult patients should use 1 drop in the affected eye(s) twice a day. Children aged 3 to 5 should use the child's dosage amount (0.25%).
Alcaftadine should be administered as an eye drop twice a day. To use the eye drop, remove the cap and tilt your head back. Gently pull down on the lower eyelid and look up. Place the dropper over the eye and use gentle pressure to release one drop into the eye. Close the eye for 1-2 minutes, then replace the cap and wipe away any excess fluid.
Common side effects associated with alcaftadine may include eye irritation, dry mouth, blurred vision, stinging or burning sensation in the eye, nausea, and headache. Less common side effects may include dizziness and dry skin. If any of these side effects worsen or persist, alert your doctor.
If too much alcaftadine is ingested at once, toxicity may occur. Symptoms of overdose may include drowsiness, nausea, vomiting, confusion, rapid or slow heartbeat, fainting, and seizures. If alcaftadine overdose is suspected, contact emergency services immediately.
Before taking alcaftadine, tell your doctor if you have any allergies, eye problems, or any other medical conditions. The safety of alcaftadine has not been established in children below 3 years of age. It is not known whether alcaftadine may cause harm to an unborn baby. Do not use alcaftadine without first talking to your doctor if you are pregnant or plan to become pregnant during treatment.
Alcaftadine may interact with other medications, including antifungals, antibiotics, diuretics, antidepressants, anti-anxiety medications, and oral contraceptives. Tell your doctor about all the medications you take, including prescription and non-prescription drugs, herbal supplements, and vitamins. Do not start a new medication without talking to your doctor.
Alcaftadine may interact with certain medical conditions, such as glaucoma, kidney or liver problems, enlarged prostate, or an overactive thyroid. Tell your doctor if you have any of these conditions before taking alcaftadine.
Alcaftadine may interact with certain medications, such as antifungals, antibiotics, diuretics, antidepressants, anti-anxiety medications, and oral contraceptives. Tell your doctor about all the medications you take, including prescription and non-prescription drugs, herbal supplements, and vitamins. Do not start a new medication without talking to your doctor.
Alcaftadine may interact with certain foods or beverages. Tell your doctor about any food or beverage interactions before taking alcaftadine.
Pregnant women should not take alcaftadine without first talking to their doctor. The safety of alcaftadine during pregnancy has not been established.
It is not known if alcaftadine passes into breast milk. Breastfeeding women should not take alcaftadine without first talking to their doctor.
If too much alcaftadine is ingested at once, toxicity may occur. Symptoms of overdose may include drowsiness, nausea, vomiting, confusion, rapid or slow heartbeat, fainting, and seizures. If alcaftadine overdose is suspected, contact emergency services immediately.
Alcaftadine should not be used if you are allergic to any of its ingredients. It should not be used in eye infections, or used in conjunction with any other medication for treating eye infections, such as Bacitracin, Neomycin, Polymixin, or Corticosteroids.
Alcaftadine should be administered as an eye drop twice a day. To use the eye drop, remove the cap and tilt your head back. Gently pull down on the lower eyelid and look up. Place the dropper over the eye and use gentle pressure to release one drop into the eye. Close the eye for 1-2 minutes, then replace the cap and wipe away any excess fluid.
Alcaftadine should be stored in a cool, dry place, away from heat and direct sunlight. It should be stored at room temperature and should not be frozen. It should also be kept out of reach of children and pets.
The volume of distribution of alcaftadine is 7 to 11L.
The half-life of alcaftadine is 6 to 8 hours.
Alcaftadine is cleared from the body through renal and biliary pathways.
See in details version Alcaftadine also Alcaftadine in bangla
Alcaftadine is an antihistamine medication used as an ophthalmic solution to prevent itching of the eyes caused by allergic conjunctivitis. It is an H1 histamine receptor antagonist that also exhibits some activity against H2 and H4 receptors, reducing allergic symptoms like itching and redness. Approved by the FDA in July 2010, it is marketed under the brand name Lastacaft as a 0.25% eye drop solution and is available both by prescription and over-the-counter (OTC).
Alcaftadine belongs to the class of ophthalmic antihistamines and decongestants. It works primarily as an H1 receptor antagonist, blocking histamine’s effects in the eyes, and has additional mast cell-stabilizing properties that help prevent the release of allergy mediators, making it a dual-action agent for ocular allergies.
Alcaftadine prevents allergic symptoms by:
Alcaftadine is indicated for:
Its primary FDA-approved use is for allergic conjunctivitis itching prevention. Off-label, it might be explored for other ocular allergic conditions, but there’s no widespread evidence for this, and such use would require physician oversight.
Alcaftadine is administered as an eye drop (0.25% solution). The typical dose is one drop in each affected eye once daily. Wash hands before use, tilt the head back, pull down the lower eyelid, and instill the drop without touching the dropper tip to the eye or any surface.
For adults, the standard dosage is one drop of Alcaftadine 0.25% in each affected eye once daily. This applies to both prescription and OTC use, with no more frequent administration recommended unless directed by a healthcare provider.
For children aged 2 years and older, the dose is the same as for adults: one drop in each affected eye once daily. Safety and efficacy are not established for children under 2, so use in this age group requires a doctor’s approval.
Since Alcaftadine is an eye drop applied topically to the eyes, food intake does not affect its use or absorption. It acts locally, with minimal systemic absorption, so timing with meals is irrelevant.
If you miss a dose, apply it as soon as you remember unless it’s nearly time for the next dose. Skip the missed dose if it’s close to the next scheduled dose, and do not double up, as this could increase irritation without added benefit.
Alcaftadine provides rapid relief, with effects on itching noticeable within 3 minutes of application after an allergen challenge. Peak plasma levels occur within 15 minutes, and its action can last up to 16 hours, supporting once-daily dosing.
Common side effects include:
Serious side effects are rare but include:
Eye irritation (burning/stinging) may occur due to the solution’s preservatives (e.g., benzalkonium chloride) or the drug’s local action on sensitive ocular tissues. This is typically transient and not a sign of harm.
Yes, though rare, allergic reactions like rash or swelling can occur, particularly in those sensitive to Alcaftadine or its components (e.g., benzalkonium chloride). Discontinue use and seek help if severe symptoms arise.
It’s contraindicated for:
It’s Category B—animal studies (rats, rabbits) show no fetal harm at high doses, but human data are limited. Use only if clearly needed, weighing benefits against potential risks with a doctor’s advice.
It’s unknown if Alcaftadine passes into breast milk or affects infants. Given its low systemic absorption, risk is likely minimal, but consult a doctor to balance benefits and potential infant exposure.
No significant drug interactions are documented. It’s not metabolized by CYP450 enzymes and has low systemic absorption, reducing interaction risks. However, separate other eye drops by 5 minutes.
Alcohol doesn’t interact with Alcaftadine due to its topical application and minimal systemic effects. Drinking won’t affect its efficacy, though alcohol may worsen allergy symptoms indirectly.
No, it doesn’t affect metabolism or cause weight gain. Its action is localized to the eyes, with negligible systemic impact.
Yes, it can be used at night or any consistent time daily. Its 16-hour duration means timing is flexible, though evening use might align with peak allergy exposure for some.
Use continues as long as allergy symptoms persist or during allergen exposure (e.g., pollen season). Stop if symptoms resolve, but consult a doctor if needed beyond a few weeks.
Yes, stopping poses no withdrawal risk since it’s not habit-forming. Symptoms may return if allergens remain present.
No, it has no effect on blood sugar due to its topical nature and minimal systemic absorption.
No, it prevents and relieves symptoms (e.g., itching) but doesn’t cure the underlying allergy, which requires allergen avoidance or immunotherapy.
Avoid:
Fatigue isn’t a common side effect. Any tiredness might relate to allergies, not the drug, given its local action.
Yes, studies show no safety or efficacy differences in the elderly versus younger adults. Use as directed.
No significant liver effects are expected. It’s metabolized by non-CYP enzymes to a carboxylic acid metabolite, with minimal systemic impact.
Yes, it’s safe for children 2 years and older at one drop daily per eye. Under 2, safety isn’t established.
The maximum is one drop per eye once daily (0.25% solution). Higher doses aren’t recommended or studied.
Dizziness isn’t a reported side effect. Its topical use limits systemic effects that could cause this.
Compared to olopatadine or ketotifen, Alcaftadine offers broader receptor antagonism (H1, H2, H4) and faster onset (3 minutes). It’s dosed once daily versus twice for some alternatives.
Yes, it reduces conjunctival redness alongside itching, with clinical significance shown at 0.25% within 7–15 minutes.
No, it has no impact on cholesterol due to its localized action.
Yes, but administer other eye drops at least 5 minutes apart to avoid dilution or interaction.
No routine tests are needed for short-term OTC use. For prolonged use, an eye doctor might check for efficacy or side effects.
No, it’s not linked to depression or mood changes due to its topical application.
No, it’s not addictive or habit-forming.
No, it’s pre-formulated at 0.25%. Diluting it could reduce efficacy—use as provided.
No, hair loss isn’t a reported side effect.
No, it’s not for bacterial, viral, or fungal eye infections—only allergic conjunctivitis.
The carboxylic acid metabolite’s half-life is about 2 hours after ocular use. The parent drug’s levels drop below detection by 3 hours.
Temporary blurring may occur right after instillation but resolves quickly. Persistent issues warrant a doctor’s visit.
No direct effect, though relieved symptoms might improve comfort during activity.
Not if eyes are red. Otherwise, remove lenses before use and wait 10 minutes before reinserting due to preservative absorption risk.
OTC versions cost $15–$30, while prescription prices vary by insurance. Generics may be cheaper.
Mild stinging is common, but persistent pain isn’t expected—consult a doctor if it occurs.
Store at room temperature (15–25°C or 59–77°F), away from heat and moisture, tightly closed. Use until the expiration date after opening.
Dr. Md. Rafiquzzaman Khan
Hematology (Blood Diseases, Blood Cancer) & BMT Specialist
Hematology Doctor in Dhaka
Dr. Shireen Akhter Khanam
Obstetrics, Gynecology Specialist & Laparoscopic Surgeon
Gynecologist in Chittagong